...
首页> 外文期刊>Inflammation research: Official journal of the European Histamine Research Society >Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis
【24h】

Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis

机译:监测嗜碱性粒细胞活化试验中CD63%的水平,并为过敏诊断提出新的参数

获取原文
获取原文并翻译 | 示例
           

摘要

The basophil activation test (BAT) is the only cellular test used to investigate basophil function for allergy diagnosis [1-4]. Most basophil activation tests (BATs) evaluate the percentage of basophils expressing the CD63 molecule on activation, in order to address a possible hypersensitivity reaction to an allergen; non-activated resting basophils do not express this tetraspanin on the cell surface but, on the contrary, cells up-regulate the molecule upon stimulation [5]. CD63 up-regulation can be related to basophil degranulation and histamine release [6], two main activation steps of basophils, which have made this molecule a good activation marker for providing a reliable test of cellular function for allergy diagnosis.
机译:嗜碱性粒细胞激活试验(BAT)是用于调查嗜碱性粒细胞在过敏诊断中的功能的唯一细胞测试[1-4]。大多数嗜碱性粒细胞活化试验(BAT)评估活化时表达CD63分子的嗜碱性粒细胞的百分比,以解决可能对过敏原的超敏反应。非活化的静息嗜碱性粒细胞在细胞表面不表达这种四跨膜蛋白,相反,细胞在刺激时会上调分子[5]。 CD63的上调可能与嗜碱性粒细胞的脱粒和组胺的释放有关[6],这是嗜碱性粒细胞的两个主要激活步骤,这使该分子成为良好的激活标记,可为过敏诊断提供可靠的细胞功能测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号